Bertrand Arnulf, Jérôme Lambert, Lionel Karlin, Cyrille Touzeau, Olivier Decaux, Aurore Perrot, Marie-Odile Petillon, Denis Caillot, Salomon Manier, Jean Marc Schiano De Colella, Mohamad Mohty, Laure Vincent, Karim Belhadj Merzoug, Xavier Leleu, Cyrille Hulin, Michael Loschi, Lydia Montes, Thomas Chalopin, Carine Chateleix, Camille Bigenwald, Jean-Richard Eveillard, Yann Guillermin, Fabrice Jardin, Alexis Talbot, Anne Lazareth, Jean-Noel Bastie, Stephanie Harel, Jill Corre, Roch Houot, Niels Moya, Pierre Bories, Titouan Cazaubiel, Noemie Bigot, Thierry Facon, Hervé Avet-Loiseau, Benoit Ferment, Philippe Moreau. "Favorable impact of patient's selection on outcome of Relapsed/Refractory multiple myeloma treated with idecabtagene vicleucel (Ide-cel) chimeric antigen receptor (CAR) T-cell therapy; Experience in french patients (Super-FENIX): An IFM study from the descar-T registry." Blood, 2025. doi:10.1182/blood-2025-4076